Top API Manufacturer Expands Innovation and Global Supply Capabilities in Pharmaceutical Development
Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing attention for ...
Pharmaceutical Executive: What elements is the conversation about bringing pharma manufacturing home missing? Charlie Lyon: ...
Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow ...
India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...
The global contract development and manufacturing organization announced March 23 it completed initial engineering studies for an expanded facility in Charles City, Iowa. Groundbreaking for the new ...
Novartis will add a new North Carolina facility for active pharmaceutical ingredient (API) manufacturing for solid dosage ...
Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...
Novartis is hardly alone in staking out manufacturing space in the Triangle. The Morrisville project lands as other big ...
As Recipharm continues to refine its footprint, the CDMO is selling its development and small-scale active pharmaceutical ingredient (API) manufacturing facility in Yavne, Israel, to Scinai ...
Novartis announces a new API facility in Morrisville, NC, as part of its $23bn US manufacturing expansion, boosting biopharma ...
Mapi Pharma Ltd. (“Mapi” or the “Company”), a late-stage clinical biopharmaceutical company specializing in long-acting injectable therapies, today announced that it is exploring the establishment of ...
I'm Vince Ippolito, Executive Chairman of the Board of Botanix Pharmaceuticals Limited, and we're pleased to present the Botanix quarterly activity report and 4C quarterly cash flow report for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results